Troglitazone Inhibits Growth of MCF-7 Breast Carcinoma Cells by Targeting G1 Cell Cycle Regulators
- 7 September 2001
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 286 (5), 916-922
- https://doi.org/10.1006/bbrc.2001.5491
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2000
- Roles of PPARs in health and diseaseNature, 2000
- An Essential Regulator of Adipogenesis and Modulator of Fat Cell Function: PPARγCell, 1999
- PPARγ-Ligands Inhibit Migration Mediated by Multiple Chemoattractants in Vascular Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1999
- Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in VivoPublished by Elsevier BV ,1999
- Differentiation and reversal of malignant changes in colon cancer through PPARγNature Medicine, 1998
- Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX miceProceedings of the National Academy of Sciences of the United States of America, 1998
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptorProceedings of the National Academy of Sciences of the United States of America, 1997
- Characterization of a candidate bcl-1 gene.Molecular and Cellular Biology, 1991